Introduction {#S1}
============

A hematopoietic stem cell (HSC) could have several fates in the body: it could remain quiescent; it could self-renew; it could commit to a particular lineage; it could migrate in response to a chemotactic cue; or it could even undergo apoptosis. In an adult human being the HSCs reside in bone marrow micro-environment comprising of several types of stromal cells along with their secretome. These micro-environmental components regulate or govern the HSC fate via signaling through various types of adhesion mechanisms. Since some of these mechanisms appear to involve short-range signals, HSCs need to be physically associated to the stromal cells: the adhesion molecules serve as the anchors that hold the HSCs in their niche. Although several studies have documented the adhesion mechanisms involved in the HSC fate decisions, the physiological cues that are translated into cellular language for the initiation of specific adhesive interactions of HSCs with stromal cells, or extra-cellular matrix (ECM) molecules and extra-cellular vesicles (EVs) secreted by them are not described to a great extent. Identification of such environmental cues could improve the outcome of clinical transplantations, as they can be harnessed to accrue benefit for the patients. Hence, in addition to reviewing the adhesion mechanisms operative in hematopoietic system, we also touch upon these aspects while describing them.

Complexity of the HSC Niche {#S2}
===========================

Hematopoietic stem cells are known to interact with a variety of cell types and extracellular components located in their close proximity. These interactions are crucially required for not only maintaining the stemness and the functionality of the HSCs, but also for governing their fate decisions. [@B143] was the first person to coin the term "HSC Niche" while referring to the specific microenvironment present in the bone marrow which supports HSC maintenance and self-renewal. The present day concept of HSC niche involves various cell types, extracellular signaling molecules, ECM molecules, physical factors, etc. ([@B167]). Recently, the EVs present in the bone marrow microenvironment secreted either by the marrow stromal cells or by the hematopoietic cells themselves have been identified as an important regulator of HSC adhesion ([@B20]).

Hematopoietic stem cells niches are thoroughly studied and characterized in invertebrate organisms such as *Caenorhabditis elegans* ([@B87]) and *Drosophila melanogaster* ([@B183]). Mammalian system is far too complex for such detailed and conclusive analyses. However, recent studies on mammalian systems have helped us to understand the indispensable role of the niche in governing the stem cell functionality. Development of several novel and sophisticated techniques such as real time imaging of cells have opened up new arena for understanding HSC and HSC niche biology. Picture of HSC niche is now becoming more explicit and the role of different niche components is now becoming a lot more comprehensive. The undifferentiated, long-term repopulating HSCs (LT-HSCs) are located near the bone endosteum and move in the direction of the central axis of the bone marrow in response to the mobilization or commitment signals ([@B104]; [@B54]). This niche, known as the endosteal niche, mainly contains pre-osteoblasts (Osteo-MSCs), osteoblasts and osteoclasts ([@B5]). Imaging of LT-HSCs for their spatial distribution confirms their presence in the endosteal zone of bone marrow ([@B187]). The studies on HSC homing show that the infused HSCs home near the osteoblasts present in the endosteal niche in about 15 h after transplantation ([@B119]). Similar studies also suggest that the HSCs reside within about 200 μm of the sinusoidal blood vessel lining in the trabecular region of bone marrow cavity ([@B15]). The histochemical studies of SLAM HSCs also reveal that majority of them are present in the close proximity of sinusoidal endothelial cells. This has led to the identification of second type of HSC niche termed as the perivascular niche ([@B85]). The components of perivascular niche are mainly endothelial cells (ECs), mesenchymal stem cells (MSCs), cytokines, chemokine (C-X-C) ligand 12 (CXCL12)-abundant reticular (CAR) cells, platelet-derived growth factor receptor-α-expressing MSCs (PDGFR^+^ MSCs), Nestin positive MSCs, Macrophages, etc.

Bone marrow (BM) is a very complex structure made up of a variety of cell types having specific spatial locations ([@B11]; [@B127]). The constantly changing dynamics of cellularity, blood perfusion and gradient of oxygen tension further adds to its complexity. A single HSC is known to receive and respond to a variety of signals emanating from the several types of niche cells simultaneously. Latest findings also show that the HSCs, though being present in their specific niches, can have cross talk with the long distance cells, which can modulate their functionality and decide their fate. These findings are now challenging the idea of anatomically distinct HSC niches and postulate that the entire bone marrow itself can be considered as a single niche, where discrete areas in the bone marrow compartment and the cell types present therein play important roles at different stages of hematopoiesis and co-ordinate the HSC maintenance, self-renewal, and differentiation ([@B167]). Thus, the molecular understanding of mechanisms involved in HSC-niche interactions/adhesions mediating the cellular cross-talk still remains one of the most important areas of research in the field.

In the embryonic developmental stages, the HSCs are known to mobilize, migrate and home to various HSC niches in a coordinated manner. For example, HSC pool is known to move from yolk sac to fetal liver, from where it moves to thymus, to spleen and finally to the bone marrow just before the birth. These processes are governed by the adhesion molecules expressed on the HSCs during these migratory processes. These adhesion molecules also play an important role in migration and homing of the donor HSCs to the recipient's bone marrow niche after transplantation. Considering their importance in clinical transplantations, the adhesion molecules are mostly studied either in the context of mobilization of the donor HSCs or their engraftment in the recipients' marrow: the processes working in exactly opposite direction of each other. Various adhesion molecules ([Table 1](#T1){ref-type="table"}) that are expressed on the HSCs and their niche cells are discussed below and are illustrated in the Graphical Abstract.

###### 

Summary of adhesion molecules expressed on hematopoietic stem cells and their counter receptors on niche components.

  Sr. no.   Adhesion molecules on HSCs   Receptor molecules in niche                                Niche component expressing receptor molecules    References
  --------- ---------------------------- ---------------------------------------------------------- ------------------------------------------------ ----------------
  1         Integrin β1αL (LFA-1)        ICAM-1                                                     Endothelial cells                                [@B146]
  2         Integrin β1α4 (VLA-4)        VCAM-1/fibronectin                                         Endothelial cells                                [@B125]
                                                                                                    ECM                                              [@B146]
  3         Integrin β1α45 (VLA-5)       Fibronectin                                                ECM                                              [@B146]
  4         Integrin β1α6 (VLA-6)        Laminin                                                    ECM                                              [@B146]
  5         Integrin β1α2                Fibronectin Fibrinogen Vitronectin von Willebrand factor   ECM                                              [@B51]
  6         Integrin β1α9                VCAM-1                                                     Endothelial cells                                [@B102]
  7         Integrin β3α5                MAdCAM Periostin                                           ECM                                              [@B82]
  8         Integrin β7α4                VCAM-1                                                     Endothelial cells                                [@B81]
  9         ESL-1                        E-selectin                                                 Endothelial cells                                [@B95]
  10        PSGL-1                       E-selectin                                                 Endothelial cells                                [@B95]
                                         P-selectin                                                 Endothelial cells                                [@B98]
  11        CD162                        P-selectin                                                 Endothelial cells                                [@B98]
  12        CD34                         L-selectin                                                                                                  
  13        CD44                         Hyaluronic acid                                            MSC ECM                                          [@B6]; [@B165]
  14        Notch                        Jagged                                                     MSCs Endothelial cells Osteoblasts Osteoclasts   [@B7]
  15        N-cadherin                   N-cadherin                                                 MSCs                                             [@B192]
  16        Eph                          Ephrin                                                     MSCs                                             [@B46]

Important Adhesion Molecules Involved in HSC Adhesion {#S3}
=====================================================

Integrins {#S3.SS1}
---------

Integrins are one of the most important classes of adhesion molecules involved in the interaction of HSCs with their micro-environment. They not only participate in cell--cell and cell--matrix interactions, but also make connections to the cytoskeleton through their cytoplasmic domains and activate many intra-cellular pathways. Most integrins interact with several different ECM proteins, and individual matrix proteins bind to several integrins ([@B73]). Owing to their characteristic bidirectional signaling mechanism, coupled with their ability to interact with various growth factor receptors, integrins are able to coordinate signals from the growth factors and the ECM molecules to support cell proliferation, migration, etc. ([@B41]).

Integrins are made up of α and β subunits that are non-covalently associated with each other ([@B73]). There are mainly 24 types of integrins formed from a combination of one α- and one β-subunits from 18 types of α- and 8 types of β-subunits ([@B156]). Integrins are classified on the basis of their constituting β-subunits. These integrins bind to various types of ECM molecules like fibronectin, vitronectin, laminins, fibrinogens, collagens as well as the complimentary receptors expressed on neighboring cells. In addition to this, integrins play an important role in providing the mechanical link between ECM and the cellular cytoskeleton. Moreover, their role as the receptors for many signaling molecules and cytokines is quite well known ([@B8]).

In the hematopoietic system, integrins are known to regulate important functions such as cell signaling, adhesion, migration and homing. The process of migration of HSCs to the specific niches in the bone marrow compartments after their transplantation is known as HSC homing. HSCs are known to express β1, β2, β3, and β7 integrins. Most common and widely studied ones is the β1 integrin, which dimerizes with α1, α2, α4, α5, and α6 to form various types of functional adhesion molecules ([@B97]). The importance of the β1 integrin in HSC migration and homing was evident by the fact that the β1 integrin knock-out embryos die during the embryogenesis ([@B67]). HSCs from β1^--/--^ chimeric embryos were unable to migrate to fetal liver marking the crucial role of β1 integrins in HSC migration and homing. Similarly, the conditional β1 knockout HSCs fail to migrate to hematopoietic organs such as bone marrow, spleen and thymus ([@B128]). Changes in the expression levels of integrin molecules have been shown to be associated with mobilization as well as homing and engraftment of HSCs. The Cyclophosphamide/Granulocyte- Colony Stimulating Factor (G-CSF) mobilized HSCs collected from peripheral blood were seen to have a down-regulated expression of integrins and these HSCs were compromised in their homing and engraftment ability. Pre-treatment of HSCs with blocking monoclonal antibody against α4 integrin function results in their decreased homing ([@B164]). Specifically, α4β1 (VLA-4), α5β1 (VLA-5), and αLβ2 (LFA-1) are important for HSC-EC adhesion and the subsequent *trans*-endothelial migration of HSCs toward the stromal cell-derived factor (SDF)-1α (CXCL12)-expressing stromal cells ([@B125]). Blocking of α5β1 integrins on HSCs before transplantation significantly reduces their homing to bone marrow ([@B175]). Along with the above-mentioned integrin molecules, α4β7 integrin has also been found to play a role in post-transplantation recruitment of HSCs into bone marrow ([@B81]). Integrin α6β1, known as CD49f, is also expressed on hematopoietic cell population and is known to regulate the homing of a specific subset of HSCs having long term multi-lineage engraftment potential ([@B120]). It is currently used as a marker for distinguishing HSCs from multi-potent progenitors (MPPs) in human hematopoietic system. Yet another integrin that plays an important role in HSC functions is αvβ3. Thrombopoietin-mediated maintenance of HSCs depends on signaling emitted by activated αvβ3 integrin ([@B159]). [@B82] demonstrated that Periostin (POSTIN), an ECM molecule, interacts with αvβ3 and regulates HSC proliferation by increasing the expression of p27Kip1 (cdkn1b). Loss of POSTIN leads to HSC proliferation coupled with loss of their functionality.

Integrin αIIbβ3 (CD41/CD61) is known to participate in cell adhesion and cell surface-mediated signaling. Its expression is mostly restricted to megakaryocytes, but a small subset of HSCs also expresses CD41. In the embryonic hematopoietic cells, CD41 is considered to be the marker for differentiation. Its expression has been shown to be associated with early stages of hematopoiesis and is tightly regulated during hematopoietic development ([@B110]). Adult HSCs also have been shown to express CD41 on their surface. These CD41^+^ HSCs accumulate during aging. They are found to be largely quiescent and exhibit myeloid bias. They also show myelo-erythroid and megakaryocyte gene priming, which is governed by Gata1 ([@B51]).

### Integrins as Regulators of HSC Adhesion in Response to Matrix Stiffness {#S3.SS1.SSS1}

An aspect that is now fast emerging is how HSCs use various adhesion molecules and receptors to respond to the changes in the stiffness of the microenvironment; integrins play a crucial role in this process. The integrin-mediated adhesion starts with initial attachment of the cells to the matrix, where integrin clustering, recruitment of adhesion-associated proteins, and the generation of focal adhesion complexes take place ([@B180]). This ability of integrins to recruit adhesion-associated proteins helps them to sense and respond to different kinds of extracellular biophysical cues of the microenvironment.

Biophysical cues such as matrix stiffness and mechanical force need critical consideration while developing matrices for stem cell maintenance and growth *in vitro* ([@B29]). In addition to providing biological cues, the ECM molecules also provide biophysical cues via various adhesive mechanisms ([@B189]). HSCs respond to the external biophysical signals by binding to ligands present on the adhesive substrates through clustering of various adhesion molecules including integrins, which initiates transduction of "outside-in" signaling in them. The bone marrow microenvironment provides a gradient of varying stiffness, which affects the HSC fate. The endosteal region of the bone is relatively stiff having Young's modulus of 40--50 kPa, as compared to the perivascular region having a modulus of about 3 kPa and the central medullary region having a modulus of 0.3 kPa ([@B56]; [@B28]). Since endosteal niche harbors quiescent HSCs having long-term engraftment ability, while perivascular niche harbors actively proliferating HSCs having short-term engraftment potential, it appears that that perhaps matrix stiffness contributes in controlling the quiescence and the functionality of HSCs. Taking a cue from the *in vivo* observations, [@B27] cultured mouse bone-marrow derived LSK HSCs in 3D matrix created using varying concentrations of type I collagen oligomers giving varying stiffness (50--800 Pa) and calvariae-derived osteoblasts. They found that indeed the decreased proliferation of LSK HSCs was associated with an increase in the matrix stiffness. LSK HSCs present within 800 Pa collagen oligomer matrices maintained the highest percentage of cells in quiescent state (G0/G1), as compared to those present within 50 Pa or 200 Pa matrices. [@B94] demonstrated that osteoblasts flatten and remodel their cytoskeleton in response to the adrenergic agonist clenbuterol. These changes increase the stiffness of the matrix, which enhances HSC adhesion and migration ([@B94]). These findings could have implications in HSC mobilization. Matrix stiffness also determines the commitment process of the HSCs. Using ECM-coated polyacrylamide surfaces of varying stiffness [@B28] showed that stiffer substrates (44 kPa) promote higher formation of CFU-GEMM (Colony Forming Unit- Granulocyte-Erythrocyte-Monocyte-Megakaryocyte), CFU-E and CFU-M (Macrophage) type of colonies, whereas softer substrates (3.7 kPa) support formation of CFU-G (Granulocyte).

Selectins {#S3.SS2}
---------

Selectins play a very important part in the homing of transplanted HSCs to the bone marrow niche. Due to the rapid association and dissociation rate constants that characterize the adhesion mediated by them, selectins play an important role in tethering and rolling of transplanted HSCs along the walls of endothelial capillaries. Selectins recognize fucosylated, sialylated, and sulfated ligands expressed on scaffold glycoproteins serving as functional counter-receptors. They are regulated at the transcriptional level, through various mechanisms such as proteolytic processing, cellular sorting, and regulated expression of glycosyl-transferases responsible for the formation of functional ligands. Each selectin molecule consists of an extracellular lectin-like domain, an EGF-like domain, and variable numbers of a consensus repeat bearing homology to complement proteins, followed by transmembrane and short intracellular sequences.

Selectin family consists of three calcium-dependent lectins viz. E-selectin, P-selectin, and L-selectin. They are involved in the recruitment of leukocytes to the sites of inflammation ([@B79]).

### E-Selectin {#S3.SS2.SSS1}

Amongst the three selectins, E-selectin has been shown to play a unique role in HSC adhesion. Under steady state conditions, very few vascular ECs present in the bone marrow express E-selectin. However, post-irradiation more than 90% of them express E-selectin and this promotes a rapid proliferation of HSCs. Consistent with this, a therapeutic blocking of E-selectin or genetic deletion of E-selectin promotes HSC quiescence ([@B178]). This approach can be applied when HSCs need to be protected during aggressive chemotherapy. Both, human and mouse HSCs express E-selectin ligands namely, PSGL-1 and CD44, but the anti-proliferative effect of E-selectin is not seen in PSGL-1 or CD44 KO mice, suggesting involvement of yet another un-identified ligand involved in E-selectin-mediated HSC quiescence. E-selectin ligand 1 (ESL-1) is expressed by primitive HSCs. Deletion of ESL-1 leads to HSC quiescence, but this effect is E-selectin-independent ([@B95]); rather, this quiescence was due to higher secretion of TGFβ1 by the mutant HSCs. Such findings throw light on complexity of the adhesion molecules and their effects of HSC fate.

### P-Selectin {#S3.SS2.SSS2}

P-selectin is typically found on the surface of activated ECs and platelets. It is reported to play an important role in recruitment of lymphocytes at the site of inflammation. In response to inflammatory signals, P-selectin gets localized on the surface of platelets and stimulates the ECs ([@B25]). Pro-inflammatory cytokine TNF-α is known to induce the expression of P-selectin in the ECs ([@B61]). P-selectin molecules are stored in the form of granules inside the cells until the signal for its surface expression is received from extracellular pro-inflammatory signaling molecules like TNF-α ([@B162]). The inhibitors of phosphatidylinositol 3 kinases (PI3K), Wartmanin and LY294002, are reported to abrogate the secretion of P-selectin granules in platelets ([@B45]). RANTES, yet another pro-inflammatory cytokine, is reported to trigger the recruitment of monocytes to the endothelium during inflammation ([@B50]). Transplantation of wild type HSCs fail to home in the bone marrow compartment of lethally irradiated P-selectin^--/--^ recipient mice, confirming the indispensable role of P-selectin in the homing of HSCs to their niche ([@B47]). LT-HSCs are reported to express CD162, the receptor for P-selectin. Culturing of LSK (Lin^--^Sca-1^+^c-Kit^+^) cells on immobilized P-selectin molecules delays the differentiation process and promotes their proliferation resulting in increased CFU-S and CFC numbers in *in vivo* mouse models ([@B43]). P-selectin is also known to negatively regulate hematopoietic progenitors via its binding to CD162 ([@B98]). Recent reports show that P-selectin is also expressed on primitive HSC population. The P-selectin expression was documented to be increased in the aged HSCs due to increased inflammation-like signaling in aged HSC niche ([@B24]). Another recent study done using quantitative mass spectrometry analysis of expressed proteins confirms the significantly higher expression of P-selectin in the HSC populations upon induction of acute inflammation, mimicking the viral infection in the mice injected with polyinosinic-polycytidylic acid ([@B60]).

Collectively, these reports show that inflammation, induced by pre-transplant conditioning regimes, infections, or aging, appears to be one of the physiological cues regulating E- and P-selectin expression on the HSCs and the ECs. However, how the inflammatory conditions lead to an increase in calcium levels required for the activation of these selectins remains to be examined.

### L-Selectin {#S3.SS2.SSS3}

L-selectin is known to bind to P-selectin glycoprotein ligand-1 (PSGL-1) and a specialized glycoform of CD44 (hematopoietic cell E- and L-selectin ligand, HCELL). Although human hematopoietic cells are shown to interact with both the molecules, under shear stress condition, human hematopoietic cells adhere strongly to HCELL, as compared to PSGL-1 ([@B40]). This L-selectin ligand activity of HCELL requires sialofucosylated N-linked glycans and is sulfation independent ([@B39], [@B40]). Earlier, we have shown that the cryopreservation of CD34^+^ human HSPCs in the presence of interleukin-3 (IL-3) and stem cell factor (SCF) increases the frequency of CD34 and L-selectin double positive HSCs in the revived cell population, along with an increased number of CFU-forming progenitors ([@B141]), indicating the importance of L-selectin expression on human HSPCs. Although L-selectin (CD62L) is expressed on HSCs and HPCs, it role in HSC adhesion remains unclear ([@B97]). It has been shown to be expressed on mobilized human CD34^+^ cells ([@B111]) and murine HSCs ([@B109]). However, L-selectin does not participate in the interaction of murine HSCs with bone marrow microvessels ([@B108]), but the expression of L-selectin was observed to be reduced on G-CSF mobilized human CD34^+^ cells 4 and 6 days post-mobilization ([@B12]). [@B59] showed that incubation of human HSPCs *in vitro* with anti-L-selectin antibody blocked clonogenic outgrowth of cells in both long-term and short-term (methylcellulose) assays ([@B59]). A progressive upregulation of L-selectin (along with other 5 genes, namely Col4a1, Entpd1, Mmp2, Tgfbi, and Timp2) was seen in fetal liver LSK cells at 14.5 dpc ([@B31]), suggesting that perhaps these genes play an important role in the HSCs during development, possibly in their migration from fetal liver to the bone marrow. [@B88] found that a higher proportion of CD34^+^ HSCs from cord blood express L-selectin, as compared with those from adult bone marrow. They further showed that the CD34^+^ cord blood HSCs expressing L-selectin form a significantly higher number of colonies, as compared to those lacking L-selectin expression.

Interestingly, L-selectin appears to have a role in the adhesion of leukemic stem/progenitor cells. [@B92] demonstrated that BCR-ABL1--expressing L-selectin--deficient progenitors could not induce CML-like leukemia after i.v. injection into wild type recipients. Their findings could be harnessed in preventing re-engraftment of Ph+ (Philadelphia Chromosome Positive) leukemic stem cells in CML patients treated by autologous transplantation. Expression of L-selectin was seen to be progressively increasing on the AML blast cells with age. This increased expression correlated with decreased apoptosis of blast cells upon treatment with cytarabine arabinoside (Ara-C). Thus, disruption of L-selectin -- bone marrow microenvironment interaction can be used as a strategy for sensitizing the leukemic cells for chemotherapy ([@B72]).

N-Cadherin {#S3.SS3}
----------

Role of N-cadherin in the regulation of HSC fate is by far the most controversial matter in the history of adhesion molecules involved in the process. Expression of N-cadherin on HSCs became a matter of hot debate as one group strongly advocated the expression of N-cadherin on the HSCs and its role in the regulation of hematopoiesis ([@B21]; [@B187]; [@B3]; [@B176]; [@B70], [@B68]; [@B64]), whereas another group vehemently denied the same ([@B84], [@B83]). To resolve the controversy, a meeting with the principal investigators was arranged ([@B99]). While the questions related to the expression of N-cadherin on HSCs and the antibodies to be used to detect the same were clarified, whether N-cadherin plays a role in HSC maintenance and regulation could not be resolved at that time. Overall conclusion regarding the first two points was that "*N-cadherin is expressed at extremely low levels in a very limited hematopoietic cell population*,*or may in fact be absent*," and "*the N-cadherin monoclonal antibody*,*MNCD2*,*is not specific for N-cadherin expression in the hematopoietic compartment.*" Whether such low level expression of N-cadherin on the HSCs as reported by the investigators translates into meaningful regulatory role is still an open question.

Notwithstanding this controversy, the unresolved matter related to the role of N-cadherin in HSC fate determination is still under active investigation in several labs. Using single cell gene expression analysis [@B4] showed the presence of N-cadherin (*Cdh2*) in the HSCs (LSK CD150^+^ CD34^--^), albeit at a variable level. Using a newly developed antibody to N-cadherin they also showed that the LSK HSCs express N-cadherin and the N-cadherin^+^ HSCs possess higher engraftment ability. On the background of previous controversy over the N-cadherin antibody (MNCD2), these data need confirmation from other labs. The same group ([@B69]; [@B4]) showed that shRNA-mediated silencing of N-cadherin in the HSCs increases their proliferation and significantly affects their long-term reconstituting ability.

As against the expression of N-cadherin in HSCs, there appears to be consensus over the expression of N-cadherin in the stromal cells, but whether it plays any role in the regulation of HSC functions remains controversial. Using genetic manipulation of Cdh2, a gene encoding N-cadherin, two groups demonstrated that deletion of N-cadherin from osteoblastic cells, both, osteoprogenitors and more mature osteoblasts, had no effect on steady state hematopoiesis or on any of the HSC functions such as engraftment, proliferation or mobilization ([@B16]; [@B57]; [@B96]). These data showed that N-cadherin does not play any regulatory role on the HSCs in the osteoblastic niche. On the other hand, using a chemotherapy model, [@B192] recently identified two classes of HSCs that exist in the BM niche; one, reserved HSCs (rHSCs, CD48^--^CD49b^--^ LT-HSCs), and the other, primed HSCs (pHSCs, CD48^--^CD49b^+^ LT-HSCs), and showed that the N-cadherin^+^ bone and marrow progenitor cells (BMSPCs) play an important role in protecting rHSCs from chemotherapy. They further found that genetic ablation of N-cadherin from BMSPCs impaired rHSC maintenance during homeostasis and regeneration. These data show that N-cadherin positive stromal cells differentially regulate HSC subsets.

In contrast to the murine data, an early study by [@B130] showed that N-cadherin is expressed on a subpopulation of human CD34^+^ HSCs and also on bone marrow stromal cells. A function blocking antibody to N-cadherin diminished the colony formation by the HSCs and also interfered with the adhesion of KG1a cells, a CD34^+^ cell line of leukemia origin, to stromal cells. [@B173] showed that N-cadherin was expressed at moderate levels in CD34^+^ HSCs isolated from cord blood (CB) and mobilized peripheral blood (MPB). Cadherin-11 was expressed on CB HSCs only. Both adhesion molecules were strongly expressed on the MSCs. They also found co-localization of N-cadherin and β-catenin at the junction of HPC and MSC, which could be disrupted using siRNA-mediated knockdown of N-cadherin or cadherin-11 as well as treatment with a blocking antibody. Such intervention also impaired maintenance of long-term culture-initiating cells (LTC-IC) in the co-culture of HSCs and MSCs. These data showed that N-cadherin-mediated adhesive interactions are important for human HSCs. However, in this study they did not determine the *in vivo* effects of N-cadherin knock out. [@B135] reported a functional difference between the MSCs isolated from murine vs. human bone marrow in terms of their support to human HSCs *in vitro*. Using atomic force microscopy (AFM)-based single-cell force spectroscopy (SCFS), they showed that human HSCs have a stronger adhesion to human MSCs, as compared to their adhesion with murine MSCs. They correlated this difference to the N-cadherin levels in these MSCs. These data suggest that N-cadherin could have a species-specific role in the regulation of human HSCs. However, more rigorous *in vivo* studies are needed to come to a definitive conclusion.

In spite of several studies dealing with the role of N-cadherin in hematopoiesis, the physiological stimulus or cue regulating the N-cadherin expression on the HSCs or the niche cells has not been examined. In this context, using murine BMSCs we showed that hypoxia up-regulates expression of N-cadherin in them and this expression is very sensitive to oxygen ([@B112]). Interestingly, we found that shRNA-mediated down-regulation of N-cadherin on stromal cells reduces the expression of CXCR4^+^ on the co-cultured HSCs, leading to a significant reduction in their chemotactic migration toward SDF1α. Such silencing of N-cadherin in the stromal cells results in an increased pool of HSCs, but the frequency of CXCR4^+^ HSCs goes down drastically. Based on our results, we speculated that perhaps the temporary normoxia that follows myeloablation as a consequence of reduction in the cell number perhaps leads to a transient down-regulation of N-cadherin in the BMSCs, thereby allowing the HSCs to proliferate. After HSC regeneration, hypoxia sets in due to high consumption of local oxygen and the expression of N-cadherin returns to the normal level. Although speculative, this study points toward the role of hypoxia as a physiological cue involved in the regulation of N-cadherin-mediated adhesion of HSCs with the BMSCs. This needs to be formally examined in *in vivo* situation.

Notch Receptors {#S3.SS4}
---------------

Notch is a cell-surface receptor that transduces short-range signals by interacting with transmembrane ligands such as Delta-like and Jagged on neighboring cells ([@B90]; [@B89]). In mammals, four Notch receptors (Notch 1--4) and five structurally related, single-pass membrane Notch ligands (Delta-like1, 3, and 4 and Jagged1 and 2) have been identified. After their synthesis, Notch receptors are cleaved by protein convertases followed by a second cleavage by the γ-secretase complex, and during their passage through Golgi they can be glycosylated by specific glycosyltransferases. Post-translational modifications determine the subsequent response to different ligands ([@B62]).

Canonical Notch signaling is activated when Notch receptor binds to its ligand leading to its cleavage and release of the Notch intracellular domain (NICD), which then travels to the nucleus and binds to CSL \[CBF1/RBPjk/Su(H)/Lag1\]. CSL interacts with many other proteins to form either repressor complexes comprising histone deacetylases (HDACs), which preserve a closed chromatin conformation, or activating complexes containing NICD and histone acetyltransferases (HATs), which open up chromatin. The extracellular domain of all Notch receptors contains 29--36 tandem epidermal growth factor (EGF)-like repeats. Interestingly, when Notch receptors and their respective ligands are present on adjacent cells (in *trans*) the interaction becomes productive, whereas when they are present on the same cell (in *cis*), the activation is inhibited ([@B150]). Productive interactions are mediated by repeats 11--12, whereas inhibitory interactions are mediated by repeats 24--29. The activation of Notch signaling triggers the expression of various target genes, such as Hes and the Hes-related (HESR/HEY) family of basic helix-loop-helix transcription repressors, which in turn regulate the expression of other genes.

Notch signaling plays an important role in the regulation of hematopoiesis starting from embryonic hematopoiesis to a definitive one ([@B18]). It has been shown to have various effects on HSCs, MSCs, osteoclasts, as well as osteoblasts ([@B7]). Activation of Notch signaling requires a direct cell--cell contact through the interaction of Notch receptors (Notch 1--4) with their ligands (Jagged1--2 and Delta like 1, 3, and 4), and hence, it plays an important role in HSC adhesion ([@B9]). Immobilized Notch ligands can induce high levels of Notch activation in the cultured HSCs, and therefore, this approach has been used for their *ex vivo* manipulation ([@B161]; [@B121]).

The presence of Notch ligands has been shown in various bone marrow stromal cells viz. ECs, osteoblasts, and MSCs. [@B44] showed that *in vivo* pro-inflammatory cues like TNFα and LPS cause an increase in Jagged 2 expression on marrow ECs and Notch1 and Notch2 receptors on hematopoietic progenitors. Thus, like P-selectin the inflammatory conditions prevailing during pre-transplant myeloablation ([@B66]) could stimulate the expression of Notch1 and Notch2 receptors on the HSCs, thereby facilitating HSC engraftment and proliferation. Butler et al. showed that ECs support a long-term expansion of Notch-activated LSK HSCs, but not of the Notch1- and Notch2-deficient ones ([@B19]). Further, this group also showed that a conditional deletion of *Jagged1* in ECs causes a decrease in the number of HSCs in steady-state conditions. This reduction was due to a significant reduction of Notch activation in LSK HSCs ([@B129]). Importantly, these Jagged-1 KO mice showed deficient hematopoietic recovery post-irradiation, underscoring the importance of Notch signaling activation by Jagged-1 expressed on bone marrow endothelial cells in maintaining both, homeostatic and regenerative hematopoiesis. [@B33] showed that a subset of human CD146^+^ perivascular MSCs expresses significantly higher levels of Jagged-1, as compared to the un-fractionated MSCs and CD146^--^ cells, and support long-term maintenance of functional human HSCs, a process partly meditated through Notch activation. Consistent with this report, we found that micro-vesicles (MVs) secreted by nitric oxide-primed BMSCs (primed MVs) contain significantly higher concentration of Jagged-1-specific mRNAs that upon transfer to the HSCs increase the level of Jagged-1 in them leading to their enhanced engraftment ([@B75]). Parathyroid hormone (PTH) is known to increase the expression of Jagged-1 in the HSCs, leading to their expansion ([@B185]; [@B177]). An interaction of Notch pathways with HoxB4 (homeobox B4) and Wnt signaling has been shown to support maintenance and self-renewal of HSC ([@B74]; [@B30]). HSCs having self-renewal capacity tend to localize to the endosteal niche present in the trabecular bone area. These HSCs exhibit significantly higher level of Notch signaling activation, as compared to those present in the long bone area. Consistent with this activation profile, osteoblasts from the endosteal regions of the trabecular bone area show increased expression of Jagged-1, Jagged-2, and Delta-like4, as compared to the osteoblasts from long bone area ([@B58]). Collectively, these studies underscore the importance of Notch signaling in the retention of functional HSCs in the niche.

Knockdown of Notch signaling pathway, including prevention of the proteolytic cleavage of the intracellular domain of Notch, leads to a decrease in the repopulation of HSC pool ([@B74]; [@B19]). Role of Notch signaling in HSC adhesion and niche retention was revealed by the study done by [@B170]. Using mice with conditional KO for *Pofut1* they demonstrated that *Pofut1*-deficient HSCs do not adhere well to Notch ligand-expressing marrow stromal cells lose their quiescent state and egress from the marrow. This was further confirmed by using neutralizing antibodies to DLL4 and JAG1. Deletion of Notch1 alone, or Notch1 and Notch2 together was found to increase the differentiation of lymphoid HSCs ([@B13]). [@B168] found that Notch 2, but not Notch 1, blockade leads to HSC mobilization. Interestingly, Notch 2 blocked, but not Notch 2 deficient, HSCs exhibited a competitive repopulating advantage and enhanced hematopoietic reconstitution. This study revealed distinct functions of two Notch receptors and suggested that this strategy can be applied to improve the outcome of clinical transplantations. Collectively, these studies underscore the importance of Notch signaling in HSC adhesion to the stromal components.

Other Adhesion Molecules Involved in HSC Adhesion {#S4}
=================================================

In addition to the major players like N-cadherin, selectins, integrins, and Notch family members, several other adhesion molecules have been shown to play important role in adhesion, retention and engraftment of HSCs in their niche. Here we review some of the other molecules identified to play a role in HSC adhesion to various stromal cells or the ECM molecules secreted by them. However, in these studies also the physiological cues regulating the HSC adhesion have not been investigated.

CD44 {#S4.SS1}
----

Although encoded by a single gene, CD44 has several isoforms arising due to both, alternate splicing and post-transcriptional modifications. CD44 standard (CD44s) is the most abundantly expressed isoform in mammalian cells. It binds to several ECM molecules, amongst which hyaluronan is the most common ligand. Hyaluronan is an important component of the HSC niche and participates in HSC lodgement in the endosteal region. CD44, hyaluronan and SDF-1 interaction has been shown to affect HSC and progenitor cell trafficking ([@B6]; [@B165]). Using a CD44^--/--^ mouse model, [@B22] showed that CD44 is critically required for the maintenance of the HSC pool, as well as in the HSC homing and lodgement into the bone marrow. Absence of CD44 brought down the % chimerism to less than 50%, but did not change the frequency of LT-HSCs. Likewise, a significantly higher number of donor WT HSCs was required to obtain 100% chimerism in CD44 KO recipient mice. Additionally, they showed that CD44 is also involved in the migration of fetal HSCs out of the liver, *via* a process involving SDF-1α. These studies underscore the importance of CD44 in the HSC adhesion.

Studies done on human HSCs also suggest the role of CD44 in their adhesion to niche components. Since adhesion molecules form the main target of HSC mobilization strategies, several investigators study the adhesion molecules in the context of mobilization. [@B155] analyzed the adhesion molecule expression on mobilized CD34^+^ HSCs and found that the CD44 TT genotype was the only factor associated with a higher risk of poor mobilization of HSCs in patients with hematological malignancies. Specifically, among the single nucleotide polymorphisms (SNPs) investigated in the study, only CD44 rs13347 was found to have an impact on the efficacy of HSCs mobilization, suggesting that analysis of CD44 SNPs may help in identifying the poor mobilizers. Such analysis could lead to the development of novel approaches of using inhibitors of adhesion molecules for HSC mobilization. [@B23] examined the correlation of expression of various cell adhesion molecules on the yield of CD34^+^ HSCs in the peripheral blood after mobilization. They determined the correlation between various cell adhesion molecules (CAMs) with the yield of CD34^+^ cells and found that poor yield of CD34^+^ HSCs correlated with a higher expression of CD44, CD106, and CD49d, as compared with those with good CD34^+^ cell yield. Mobilized CD34^+^ HSCs showed a reduced expression of several CAMs like CD44, CD106, CD135, CD49d, and CD11a, but this did not correlate with the yield. These data show the importance of various adhesion molecules in the mobilization of HSCs required for clinical transplantations and suggest that alternate strategies involving targeting of these adhesion molecules might be required to be applied in case of poor mobilizers. [@B103] used the HSC adhesive properties of CD44 and CD43 to make a technical advancement in the time-lapse microscopic studies on HSCs. They demonstrated that seeding of murine LSK HSCs or human CD34^+^ HSCs on plates coated with antibodies to CD44 and CD43 reduced their mobility and enabled colony formation in liquid cultures, increased imaging throughput in time-lapse microscopy, and also facilitated media change without affecting cell positions ([@B103]).

SDF-1α/CXCR4 Axis {#S4.SS2}
-----------------

The success of HSC transplantation critically depends on the ability of transplanted HSCs to mobilize, home, migrate, and efficiently engraft in the bone marrow niche. SDF-1α (CXCL12)--CXCR4 axis plays a crucial role in the process ([@B14]; [@B35]; [@B80]). SDF1α provides a chemotactic cue to the transplanted HSCs, and once they engraft, it helps in the retention of the HSC via its interaction with CXCR4. Deletion of either Sdf1 or Cxcr4 is lethal in late embryonic stages, as these embryos lack bone marrow hematopoiesis ([@B115]; [@B194]). However, deletion of Cxcr4 in adult HSCs does not affect their homing and engraftment, suggesting that other mechanisms compensate for its loss ([@B154]; [@B118]).

Both, HSC retention and mobilization are largely governed by SDF-1α- CXCR4 axis and by α4-integrin signaling. Both pathways are dependent on c-kit activity. Inhibition of c-kit kinase affects HSC mobilization in response to either CXCR4 antagonists or α4-integrin blocking agents and also prevents the retention of CXCR4^+^ HSCs in the bone marrow.

Some adhesion molecules like endolyn (CD164) have been shown to impart specificity to the HSC-niche interactions mediated by the SDF1α-CXCR4 axis. [@B172] have shown that CD164, a member of sialomucin family of adhesion receptors, associates with CXCR4 and regulates the adhesion of CB-derived CD34^+^ cells to bone marrow stroma and promotes cycling of CD34^+^ human HSCs. They further showed that use of a function disrupting antibody or CD164 knock down by RNAi significantly inhibits the migration of CB-derived CD133^+^ HSCs toward SDF1α *in vitro*. They further showed that CD164 associates with CXCR4 in the presence of SDF1α and fibronectin, followed by the association of CXCR4 with the integrins VLA-4 and VLA-5. This interaction leading to the activation of PKC-zeta and Akt signaling gets disrupted in the absence of CD164. [@B126] found that bovine growth hormone transgenic mice have a larger number of LSK HSCs having up-regulated SOCS1 and SOCS3 expression and impaired CXCL12(SDF1α)-induced function in their peripheral blood, as compared to control mice. CXCR4 expression was, however, not affected in these HSCs. This effect was recapitulated by exogenously provided growth hormone. These observations suggested a role for SOCS in controlling CXCL12-mediated HSC retention in bone marrow. [@B148] reported that Robo4^--/--^ HSCs display poor localization to bone marrow niches leading to poor engraftment. Interestingly, loss of Robo4 led to up-regulation of both Scf1 and Cxcr4, perhaps as a compensatory mechanism. Robo4 deletion also affects the efficiency of HSC mobilization, demonstrating that HSC mobilization involved inhibition of both, Cxcr4- and Robo4-mediated niche interactions.

Eph and Ephrins {#S4.SS3}
---------------

Expression of Eph (erythropoietin-producing hepatocellular) molecules and their cognate ligands Ephrins on the HSCs and stromal cells has been documented by several studies ([@B117]). EphA1--Eph5 and ephrinA1-ephrin-A5 is expressed by murine HSCs ([@B157]). Human bone marrow-derived MSCs have been shown to express high levels of EphB1, 2, 4 and ephrin B1, B2, where Eph-ephrin interactions regulate bone remodeling ([@B117]). Several studies have shown that EphB4/ephrin-B2 interaction regulates stromal cell support of HSCs, especially during erythropoiesis ([@B153]; [@B171]; [@B46]). CB-derived HSCs have been shown to express EphB4 ([@B171]; [@B46]), while its ligand, ephrin-B2, was found to be expressed on MSCs ([@B122]; [@B117]). EphB4 expressed by stromal cells modulates ephrin-B2 expression levels and affects transmigration of HSCs underneath the stromal layer ([@B122]). Disruption of EphB4/ephrin-B2 interaction with a peptide inhibitor or shRNA specific for EphB4 in the MSCs reduced their HSC-supportive ability *in vitro* ([@B117]). Consistent with these findings, mouse bone marrow-derived MSCs from transgenic EphB4 mice exhibited an enhanced HSC-supportive capacity ([@B190]; [@B117]).

Ephrin-A5 has been reported to enhance HSC trafficking and adhesion ([@B157]) via phosphorylation of paxillin, a downstream effector of integrin function. An intraperitoneal injection of EphA3 protein into mice mobilized the HSCs into the peripheral blood, whereas peptide-mediated blocking of EphA3/ephrin-A5 interactions affected the *in vivo* homing properties of HSC ([@B157]).

Esam1 {#S4.SS4}
-----

[@B124] identified endothelial cell-selective adhesion molecule 1 (Esam 1) as a novel HSC marker in purified murine HSCs. It mediates homophilic calcium-independent adhesions. Esam1 KO mice did not show severe hematopoietic defect, but their marrow had higher number of HSCs and fewer T cells. *In vitro* these HSCs gave rise to more granulocyte/monocytes and *in vivo* gave a higher T cell: B cell ratio when transplanted into congenic mice. These studies suggest that Esam1 may play role in HSC proliferation and lineage commitment.

Cytohesin1 {#S4.SS5}
----------

Cytohesin1 (CYTH1), a guanine-nucleotide exchange factor for multiple guanosine triphosphate (GTP)--binding protein, forms a complex with integrin β1 and αL to mediate adhesion to ICAM1. However, it was not studied in the context of HSC adhesion. Using a CYTH1 knock out HSCs, [@B132] showed that it is critically required for the adhesion of CB-derived HSCs to primary MSCs, fibronectin and ICAM1 and 2. Although these HSCs showed a reduced ability to engraft and give rise to long-term engraftment in NSG mice, the engraftment defect was not complete indicating that other mechanisms could rescue the CYTH1 deficiency. CYTH1-deficient cells also showed reduced integrin β1 activation, suggesting that CYTH1 mediates integrin-dependent functions.

ICAM-1 {#S4.SS6}
------

Intercellular adhesion molecule 1 (ICAM-1) has been shown to maintain quiescence of HSCs and also their repopulation in the niche ([@B102]). ICAM-1^--/--^ mice showed expansion of HSC having impaired quiescence and myeloid bias. ICAM-1-deficient HSCs exhibited normal reconstitution capacity during serial transplantation; however, transplantation of wild type HSCs in ICAM-1^--/--^ mice showed that ICAM-1 deficient niche affects HSC quiescence and fails to retain HSCs in the bone marrow. These data revealed the role of ICAM-1 as an important adhesion molecule involved in the retention of HSCs in the bone marrow niche.

Serum Response Factor (Srf) {#S4.SS7}
---------------------------

The serum response factor (*Srf*), a transcription factor, regulates genes controlling cytoskeletal components involved in cell spreading, adhesion, and migration. *Srf* binds to CC(A/T)6GG (CArG) motif, but its transcriptional activity depends on various signal-regulated cofactors. [@B131] found that Srf plays a role in HSC adhesion. They found that conditional deletion of *Srf* in BM cells expanded HSCs and multipotent progenitors (MPPs), without having much effect on cell cycle dynamics. However, *Srf* loss resulted in defect in mature cell formation and severe thrombocytopenia. *Srf*-null HSCs also showed reduced engraftment properties. *Srf* was found to control the genes governing cell migration and adhesion. *Srf*-null HSCs had impaired expression of the integrin network and decreased adherence *in vitro*. Consistent with this, the *Srf*-null mice had increased numbers of circulating HSCs in their peripheral blood. These studies suggest that *Srf* regulates HSC adhesion through HSC-ECM interactions and integrin signaling.

Role of Glycosylation Signatures in Functionality of Adhesion Molecules {#S5}
=======================================================================

Selectin binding activity of adhesion molecules expressed on hematopoietic cells and endothelial cells is determined by specific glycoproteins produced by post-translational modifications. These modifications are carried out by the activity of very specific enzymes known as glycosyltransferases. These enzymes link the serine or threonine residues of proteins to oligosaccharides capped with sialyl Lewis × moiety, α2--3 sialylated, α1--3 ucosylated tetrasaccharides ([@B105]). Interaction of L-selectin molecules expressed on hematopoietic cells and their receptors play important role in homing of these cells to the specified tissues, mostly having high endothelial venules (HEVs). Various types of HEVs having hematopoietic cell binding capacities are found in different secondary lymphoid organs ([@B63]).

Initial *in vitro* experiments showed that the anti- L-selectin antibody, MEL-14 blocked the binding of hematopoietic cells to HEV in frozen tissue sections ([@B49]). The *in vivo* experiments also confirmed that the blocking L-selectin using MEL-14 antibody restricted the HSC homing ([@B78]). The fact that the hematopoietic cells can efficiently bind to the L-selectin receptors which have disrupted peptide epitopes ([@B151]), but not with those treated with sialidase ([@B138], [@B137]), suggests the involvement of polysaccharides in the binding process. *In vivo* treatment of mice with intra-venous injections of sialidase diminished the *in vivo* homing of HSCs confirming their role in the active binding of these adhesion molecules to their receptors ([@B138], [@B137]).

Many of the adhesion receptors like selectins and integrins have distinct glycosylation signatures that are considered vital to their roles in homing of HSCs ([@B97]). Most of the selectin ligands such as PSGL-1, CD34, CD44, GlyCAM-1, MADCAM-1 that are expressed on HSCs are mucin-type glycoproteins having sialylated, fucosylated glycan chains ([@B78]). Selectins recognize the tetrasaccharide structures like sialyl Lewisx (sLex) displayed at the ends of these long glycan chains or glycolipids, however, purified sLex tetrasaccharide does not completely block the selectin-mediated cell adhesion ([@B149]). Although most hematopoietic cells express PSGL-1 (CD162), a well-characterized selectin receptor that binds to all three selectins, they can adhere to selectins only when glycosyl-transferases required to generate the sLex tetrasaccharide are co-expressed. In particular, fucosyl-transferase (FucT)-VII is absolutely essential to generate functional selectin receptors. Fut7^--/--^ leukocytes cannot adhere to P- and E-selectin, even though they express PSGL-1 ([@B107]). Observations made in GlcNAcT-I null as well as PSGL-1 null mice show that these receptors show more active binding with P-selectin compared to E-selectin ([@B42]; [@B186]; [@B181]). Similarly, sialomucin CD34 which is expressed on primitive human hematopoietic cells and is considered to be a major human HSPC marker is an L-selectin receptor ([@B10]). On the other hand, mice lacking CD34 expression are seen to have normal hematopoietic cell homing activity ([@B26]). Parallel to this scenario, CD34 is considered to be the HSPC marker in human system, while it has no definite marking in murine system. These studies also underscore the need to study these adhesion molecules in detail across various animal systems.

Integrins interact with ECM molecules to form complex multi-protein structures, which link the ECM to the actin skeleton, thereby initiating bidirectional signaling. Both ECM molecules and integrins are glycoproteins, and *N*-glycans are known to modulate their conformation and regulate their functions. Great variations in both the number and the distribution of *N*-glycosylation sites are found in α and β subunits of integrins. Especially, the ability of integrins to form functional dimers depends on N-linked oligosaccharides ([@B76]). Enzymatic removal of sialic acid residues is known to increase the fibronectin binding activity of β1 integrins ([@B144]). In other studies the *N*-glycosylation was found to be important for pairing of α and β subunits of integrins ([@B193]), which is important for acquiring the required conformational changes in these subunits for binding. Interestingly, unnatural N-glycosylation of β1 subunit in the α5β1 integrin increases its active ligand-binding conformation, suggesting the importance of glycosylation in acquiring ligand-binding changes in integrins ([@B106]). Glycosylation status of various integrins is altered in various cancer cells, and these changes modulate tumorigenesis and metastasis ([@B163]; [@B52]). *N*-glycans are known to play important roles in HSC adhesion and migration by modulating the function of integrins. Thus, it becomes necessary to study the role of glycosylation signatures in the modulation of various HSC properties such as migration, homing and engraftment.

Other Factors Affecting HSC Adhesion {#S6}
====================================

Role of Stromal Cell-Derived EVs in HSC Adhesion {#S6.SS1}
------------------------------------------------

Recent literature shows that EVs form one of the important mediators of intercellular communication. Apart from the larger vesicles released by the cells undergoing apoptosis (apoptotic bodies, \>1,000 nm in size), EVs are also secreted by healthy cells, either constitutively or after activation. These EVs are classified into two main subtypes, namely, micro-vesicles (MVs, up to ∼1,000 nm in diameter) and exosomes (40--100-nm diameter;[@B55]; [@B32]).

Exosomes are formed by fusion of multi-vesicular endosomes (MVE) with the plasma membrane, whereas MVs are shed by outward blebbing of the plasma membrane ([@B65]; [@B189]). MVs and exosomes are generally separated by differential ultra-centrifugation of body fluids such as blood, urine etc. or conditioned media of cultured cells and characterized by electron microscopy. It may be noted that smaller MVs (100 nM) are also secreted by many cells and they could interfere in the separation process. Both, MVs and exosomes contain membrane proteins that are known to cluster at the plasma membrane or at endosomes. Tetraspanins such as CD63, CD81, CD82, CD53, and CD37 are the most commonly used identification markers for the purified preparations of EVs, but these markers cannot distinguish between MVs and exosomes. Due to their endosomal origin, exosomes contain endosome-associated proteins, e.g., Rab GTPase, SNAREs, Annexins, and flotillin ([@B160]). In spite of the differences in their size and mode of biogenesis both, MVs and exosomes function similarly when released into extra-cellular space by binding and fusing to their target cells. Exosomes are formed in a regulated manner within the cell and being part of the endosome pathway, they are considered more likely to transport adhesion molecules, receptors and other molecules to nearby or distant cells to generate a specific function, as compared to the MVs. However, as compared to exosomes, the mechanism involved in the biogenesis of MVs is not yet completely understood. Also, most studies do not clearly define the origin of the EVs under study, making it difficult to assign the reported effect(s) to either MVs or to exosomes. Making a clear distinction between these two types of EVs could facilitate a better understanding of the role played by each of them. Recent literature shows that EVs form one of the important mediators of crosstalk between the HSCs and their microenvironment. Stromal cell-derived EVs are being studied in the context of HSC biology. These EVs have been shown to mimic the immuno-regulatory property of the parent cells ([@B91]; [@B2]; [@B166]). Likewise, they have also been shown to have salutary effects on the HSCs in terms of their proliferation, viability, differentiation, protection from irradiation-induced toxicity, rejuvenation etc. ([@B37]; [@B53]; [@B174]; [@B182]; [@B142]; [@B152]; [@B93]; [@B113]). MVs (microvesicles) and exosomes, which are the subpopulations of EVs have also been explored for their differential effects on HSC regulation. ESC-derived MVs have been shown to reprogram HSPCs by horizontal transfer of mRNAs and protein ([@B133]). Similarly, Endothelial Progenitor Cells (EPC)-derived MVs are reported to increase the angiogenesis in the ECs ([@B38]). CB-HSCs when treated with MVs derived from leukemic cell line Jukrat resulted in an increased cell number and viability, and a decrease in p53 tumor suppressor gene expression, as compared to the HSCs treated with normal bone marrow cell-derived EVs ([@B134]). Exosomes derived from MSCs isolated from bone marrow of multiple myeloma (MM) patients showed a significantly different miRNA and protein content than the exosomes derived from their normal counterparts leading to an enhanced myeloma tumor growth suggesting that the differential secretion of exosomes from bone marrow-derived MSCs under altered conditions ([@B136]). The study of exosomes uptake and their effect on HSCs clearly shows that the HSCs preferential take up exosomes secreted by HSC-supportive cells from the mixture of exosomes from HSC-supportive and HSC non-supportive cells. These exosomes also support the proliferation of co-cultured HSCs and improve their survival by reducing apoptosis levels in them ([@B152]). Exosomes from acute myeloid leukemia directly repress HSC activity by decreasing clonogenicity, reduced CXCR4 and c-Kit expression and repression of several hematopoietic transcription factors. These exosomes were also shown to increase mobilization of HSCs through down-regulation of SCF and SDF-1α in stromal cells ([@B71]), hinting at their important role in HSC adhesion and mobilization. However, effects of EVs on the HSC adhesion have not been extensively studied.

Chemotactic migration via CXCR4-SDF1α axis of HSCs to the bone marrow micro-environment and their subsequent adhesion to the stromal cells via various adhesion molecules are crucial pre-requisites in successful transplantation. MSC-derived EVs were shown to up-regulate CXCR4 expression on them leading to their augmented *in vivo* migration to the BM niche in NSG mice ([@B37]). However, they did not find any specific miRNA regulating CXCR4, and hence, one can speculate that either CXCR4-specific mRNA was transferred from the EVs to the HSCs or the CXCR4 expression was enhanced by some indirect mechanisms. Using murine system, we have reported that the HSCs co-cultured with micro-vesicles (MVs) of nitric oxide-primed BMSCs (primed MVs) show significantly higher expression of CXCR4, at both, mRNA and protein levels ([@B75]). Since the level of CXCR4-specific mRNA in the primed MVs was similar to control MVs, but that of VEGF-A was significantly higher, this increased expression of CXCR4 could be correlated with the activation of primed MV-mediated VEGFA-eNOS pathway in the HSCs, as CXCR4 has been shown to be a direct target of nitric oxide ([@B34]). Human MSC-derived MVs have been shown to harbor adhesion molecules such as fibronectin, ezrin, IQGAP1, CD47, integrins etc. ([@B86]). Likewise, [@B113] showed that the EVs isolated from fetal calvaria-derived osteoblastic cells contained cell adhesion molecules like EPCAM, ICAM1, and ITG7. Mobilization of HSCs involves disruption of their adhesion to stromal cells. [@B36] showed that infusion of MSC-derived EVs resulted in mobilization of HSCs into the blood stream, but the molecular mechanism involved in this process was not studied. Although this study could be taken as an indicative of role of EVs in HSC adhesion, direct effects of EVs on HSC adhesion to stromal cells have not been examined. Such studies would be of immense importance in clinical transplantations. Our lab is actively involved in studying this aspect.

Aging is known to affect the homing and engraftment ability of HSCs ([@B100]). We have shown that a brief exposure of young HSCs with the EVs secreted by aged MSCs significantly reduces their engraftment by reducing their autophagy-inducing mRNAs ([@B93]). Consistent with our earlier studies ([@B147]); we could attribute this to aging-mediated increase in the activation of AKT in the stromal cells. Although, we did not assess the effect of such reduced autophagy on the expression of adhesion molecules on young HSCs, aging seems to be one of the physiological signals altering the HSC adhesion to stroma. Since aging is considered as a consequence of chronic low-grade inflammation ([@B140]), it is possible that other inflammatory conditions could also affect the macromolecular composition of stromal EVs and affect HSC adhesion. This aspect needs to be formally examined.

Collectively, the reports suggest that EVs from specific type of niche cells can support HSC survival and maintenance. The HSCs are regulated by EV-mediated cross-talk with the niche and other types of distantly located cells, and alteration in the micro-environment and the resultant altered profile of EVs (MVs or exosomes or their relative balance) produced by niche cells may alter the HSC response and their functionality. Thus, HSC functionality can be modulated by "priming" the parent cells with pharmacological means to modulate their EV profiles for their application for therapeutic purpose ([@B77]).

### EVs Secreted by Hematopoietic Cells and Their Effect on HSC Adhesion {#S6.SS1.SSS1}

Besides the cells of non-hematopoietic origin, HSC niche consists of hematopoietic cells like megakaryocytes (Mgk) ([@B17]; [@B191]) and macrophages ([@B179]) that affect HSC fate. Since almost all cells secrete EVs, the EVs secreted by Mgk and macrophages could also affect HSC adhesion. [@B179] have shown that marrow macrophages maintain the HSCs niche and their removal leads to HSC mobilization, suggesting that macrophages are involved in HSC adhesion to stroma. Likewise, Mgk are required for expansion of osteoblasts after irradiation, and thus, indirectly regulate HSC engraftment ([@B123]). Whether macrophages and Mgk participate in HSC adhesion to stroma via the EVs secreted by them needs to be examined. [@B188] have suggested that the EVs secreted by aging immune cells may differ in their molecular content. However, in this study the effect of such altered EVs on HSCs was not examined. It will be interesting to see whether the EVs of aging immune cells affect adhesion molecule profile of the HSCs.

Effect of Aging on HSC Adhesion {#S6.SS2}
-------------------------------

In specific conditions such as aging, HSCs show a reduced expression of CXCR4 ([@B145]) and consequent reduced response to the chemokines ([@B1]). Adherence ability of HSCs to stromal cells is also known to be compromised during aging. Aged mice show fivefold increase in mobilized HSC numbers confirming their diminished adhesive properties ([@B184]), which could be due to decreased levels of SDF-1α in their bone marrow ([@B158]). Further, the compromised property of aged bone marrow niche to retain HSCs was also documented earlier; wherein the young HSCs when transplanted to aged recipients demonstrated reduced frequency of homing, as compared to those transplanted to young recipients ([@B100]). Aged bone marrow changes from an osteoblast-dominant to an adipocyte-dominant one. This change in the microenvironment coupled with the reduced bone density might be the reason for the aging-mediated decrease in the HSC functionality. The studies aiming at understanding the changes in aged BM physiology and attempts to modulate it could help us in finding the treatment for various malignant and non-malignant gerontological hematopoietic diseases.

Orchestration of HSC Adhesion Mechanisms in Homing and Engraftment of HSCs {#S7}
==========================================================================

Homing of HSCs to the appropriate place in the bone marrow niche is an important process involving coordinated functioning of various signaling and adhesion molecules. Individual roles of most of the adhesion molecules have been discussed earlier in this review. However, these molecules do not operate independently, but rather work in an orchestrated manner to guide the infused HSCs to their exact destination in the bone marrow. The processes of migration and homing require sequential formation and disruption of various adhesion bonds between the HSCs and the bone marrow cells. The important steps involve the rolling of HSCs on the walls of endothelial capillaries, followed by their further migration into the bone marrow compartment and finally their engraftment in the specific HSC-supportive microenvironment.

Bone marrow is a primary organ of hematopoiesis and large numbers of hematopoietic cells are known to traffic from and to the bone marrow. Thus, for efficient homing of HSCs to the bone marrow very specific mechanisms are required to selectively attract the HSCs to the bone marrow niche. First, the intravenously infused HSCs migrate to the bone marrow niche via chemotactic migration mediated by the SDF1α-CXCR4 axis. Thereafter, the L- and P- selectin molecules expressed on the ECs present on the lining of the blood sinusoids and capillaries in bone marrow get involved in the homing process, as the ligands for these selectins are expressed on the HSCs ([@B139]). Once brought in the close proximity of the ECs, HSCs interact with them and the process of initial tethering and rolling along the walls of endothelial capillaries begins. The specificity of this process can be underscored by the observation that only the bone marrow sinusoids and capillaries support the rolling process of HSCs on their endothelial linings and such process is not supported by the adjoining bone vessels ([@B108]). Further, as mentioned before, only E- and P-selectins are involved in this initial process of HSC rolling, whereas L- selectin does not play any role in this process. Another selectin-independent mechanism of the HSC rolling involves the interaction of α4 integrin with VCAM-1 molecules expressed on ECs ([@B108]).

Once adhered to the endothelial lining, HSCs undergo *trans*-endothelial migration to migrate along the SDF-1 gradient. E- and P- selectins once again play an important role in the recruitment of HSC to the ECs and subsequent *trans*-endothelial migration ([@B48]; [@B116]). HSCs are known to express high levels of α4β7 integrins, which drive the adhesion of HSCs to the ECs to initiate the migration. HSCs knocked out for α4β7 integrins show reduced expression of CXCR4 -- the chemokine receptor for SDF-1, and show reduced ability to migrate and home to bone marrow niche. Lethal irradiation is known to induce the mucosal addressin cell adhesion molecule-1 (MAdCAM-1), the ligand for α4β7 integrin, on the bone marrow ECs. Expression of MAdCAM-1on ECs promotes the increased adhesion of HSCs to the endothelium, resulting in their successful homing and engraftment ([@B114]).

The integrin molecules further direct the homing of the LT-HSCs. Integrins exhibit a special phenomenon in that they need to acquire the specific conformationally activated state to bind to their ligands. Various types of soluble extracellular molecules such as cytokines, cations, etc. acting at different concentrations, help in the formation of the various conformations of integrins having different affinity for the specific ligands expressed on the neighboring cells. Divalent cation binding sites are present near the ligand binding site on the integrin molecules, thereby allowing the conformational flexibility for binding. Studies show that the Mg^2+^ at a concentration of about 1mM initiates β1 integrin activation in the absence of any cytokines, while the Ca^2+^ concentration of more than 10mM inhibits β1 integrin activation by cytokines. The site of active bone resorption near the osteoclasts has normally more than 10 mM concentration of Ca^2+^ making it an inhabitable place for HSC adherence and homing. On the other hand, Mn^2+^ which is known to be the super-activator of β1 integrin is found at high concentration in compact bones niches, making it a favorable place to home for the HSCs ([@B97]).

Future Perspective {#S8}
==================

The importance of adhesion mechanisms in the success of clinical transplantation evoked an immense interest in the adhesion mechanisms involved in the HSC-niche interactions. Several studies have identified various types of adhesion molecules expressed on the HSCs and also on their niche cells. Most studies have used genetic or antibody-/peptide-mediated function-blocking approach. However, very few studies have revealed the physiological cues initiating these mechanisms. If these cues could be identified they would not only improve the efficacy of HSC transplantations, but might also contribute toward the regenerative medicine as well.

The role of EVs in the HSC adhesion needs to be investigated in greater details. Since EVs could form "ready-to-use" biologic, identification of their role in HSC fate determination may accrue clinical benefits.

Notably, none of the studies have looked at adhesion mechanisms operative within the stromal cell population. During steady-state conditions the stromal cells may not interact with each other, however, it is quite possible that under the influence of physiological cues like hypoxia, inflammation etc. and also in response to the secretome of HSCs receiving differentiation signals (e.g., EPO), the stromal cells also could initiate homotypic (e.g., MSCs to MSCs) or heterotypic (e.g., MSCs to osteoblasts or ECs) interactions among themselves and these interactions could in turn lead to HSC adhesion and fate change. This possibility also needs to be addressed. Such studies could provide better insight to the mechanisms involved in HSC adhesion.
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